Skip to content
Pharma Observatory a Scientist.com platform

Organization (Academic)

UNIVERSITY OF DENVER

ClinicalTrials.gov lists UNIVERSITY OF DENVER as lead sponsor of 16 trials.

US Academic
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

4 0 1994 2026

Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 2 registered with a 2026 start date. The dashed outline is the pace from the 2 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 1.4 trial starts a year over the five years to September, under the 5 a year the method needs.

Logo Unknown author Unknown author, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.

This page covers UNIVERSITY OF DENVER: 16 lead-sponsored trials and 2 legal-entity registrations.

Get the UNIVERSITY OF DENVER report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (22)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Anxiety Disorders 2
Stress Disorders, Post-Traumatic 2
Substance-Related Disorders 2
Anxiety, Separation 1
Back Pain 1

Trials by start year as sponsor or collaborator (15)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 2
2025 1
2023 3
2021 2
2020 3
2018 1
2017 4
2016 2
2015 3
2014 1

Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Sponsor delivery record (1)

Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.

Sponsor delivery record
Enrollment Timeline
83% hit target (n=6) 71% on time (n=7)

Journals published in (22)

Shown in this order: most published in first.

Journals published in
Journal Publications
Journal of child psychology and psychiatry, and allied disciplines 3
Journal of manipulative and physiological therapeutics 3
Behaviour research and therapy 2
JAMA pediatrics 2
Affective science 1

US granted patents (1)

Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.

US granted patents
US patents granted Granted in the last 5 years Most recent grant
16 10 2025-12-09

Financing and grant events (116)

Shown in this order: most recent first.

Financing and grant events
Date Round type Amount (USD) Source
2025-09-15 NIH grant 203,025 Reporter
2025-09-06 NIH grant 138,809 Reporter
2025-08-29 NIH grant 704,875 Reporter
2025-08-19 NIH grant 407,562 Reporter
2025-08-05 NIH grant 741,405 Reporter

Organization relationships (2)

Shown in this order: most evidence first.

Organization relationships
Related organization Relationship Evidence
Boston University Co sponsors trial with 1
Denver Health and Hospital Authority Co sponsors trial with 1

Latest dated events (159)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-08-21 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-08-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-12-09 Patent granted Granted US patents (PatentsView / USPTO)
2025-09-15 NIH grant Funding rounds and grants (NIH RePORTER + SEC EDGAR)
2025-09-06 NIH grant Funding rounds and grants (NIH RePORTER + SEC EDGAR)

CLIA clinical laboratory certificates (1)

CLIA clinical laboratory certificates
Lab Certificate Status
UNIVERSITY OF DENVER Certificate of accreditation Terminated

Biomarker capability evidence (9)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
ADM Trial sponsor Named in trial inclusion criteria
DPP4 Trial collaborator Named in trial inclusion criteria
PNN Trial collaborator Exploratory endpoint in a trial
TRIT1 Trial collaborator Named in trial exclusion criteria
ADM Trial sponsor Mentioned in trial text

Biomarkers this organization publishes on (75)

Shown in this order: most publications first.

Biomarkers this organization publishes on
Biomarker Publications
IL6 4
SLC6A4 3
AP2B1 2
BDNF 2
NR3C1 2

On Scientist.com

UNIVERSITY OF DENVER is listed as a research supplier in the Scientist.com network.

Website
www.du.edu

Source: Scientist.com supplier network

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, approved assets, sec-reported annual financials, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, and workforce and board diversity, as filed.

Work with University of Denver on Scientist.com

For prices, more details, or to contact University of Denver, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.